| CYSB2400167 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSL2400365 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2024-06-04 | | Ningbo Kunpeng BIOTECH Co Ltd | | | view |
| CYSB2400139 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400073 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-03-18 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2400054 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-02-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2400053 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-02-29 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2400058 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2024-01-25 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| CYSB2300217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-11-29 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2300169 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(原15) | Supplementary Application | 2023-09-16 | | Zhejiang Hisun Pharmaceutical Co Ltd | | | view |
| CYSB2300089 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(原15) | Supplementary Application | 2023-04-27 | | Zhejiang Hisun Pharmaceutical Co Ltd | | | view |
| CYSB2300084 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-04-19 | | Gan & Lee Pharmaceuticals | | | view |
| CXSL2300177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Nanjing Han Xin Pharmaceutical Technology Co Ltd | | | view |
| CYSB2300032 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-02-09 | | Gan & Lee Pharmaceuticals | | | view |
| CYSB2300010 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2300011 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200235 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-28 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2200228 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
